Early pre-clinical models explored the contribution of IL-6 in pleural effusions to constitutional MM symptoms (Table S5), and cell line experiments suggested that anti-IFN-γ therapy could alleviate these symptoms [238]. This evidence concerns the gene IL6 and Pleural effusion.